Protein kinase inhibitors as therapeutics in neurodegenerative and psychiatric disorders
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Saracatinib (AZD0530) is a tyrosine kinase inhibitor undergoing Phase II trials and has been demonstrated to improve memory in transgenic mice models of AD.
“The tyrosine kinase inhibitor saracatinib (AZD0530 (labeled as 14, Figure 5)) is undergoing Phase II trials [174,175,176] and has been demonstrated to improve memory in transgenic mice models of AD.”
From Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease (2024) · cites this paper as [176]
The citation lists haven’t been fetched yet
References 443 · Cited by 8
- Authors
- Tridente, G., Jana, A., Nath, A., & Ashraf, G. M.
- Affiliations
- University of Verona (IT)
- KIIT University (IN)
- Indian Institute of Science Bangalore (IN)
- University of Sharjah (AE)
- Venue
- Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders
- Publisher
- Elsevier
- Published
- 2023
- Pages
- 403-573
- OpenAlex
- W4383426634
- Cited by
- 8
- References
- 443
- Citations by year
- 2025: 3 · 2024: 4 · 2023: 1
- FWCI
- 11.40
- Type
- book chapter
- Language
- en
- Open access
- closed
- Licence
- Locations
- Elsevier eBooks (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- protein kinase inhibitors, neurodegenerative diseases, mental illness, drug repurposing, clinical trials, multitarget kinase inhibitors, dasatinib, bosutinib, masitinib, saracatinib, tofacitinib, rapamycin, tideglusib, antisense oligonucleotides, nusinersen, tofersen, drug safety, drug efficacy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
